1.         Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Enzyme Replacement Therapy Market – By Enzyme Type

1.3.2        North America Enzyme Replacement Therapy Market – By Therapeutic Conditions

1.3.3        North America Enzyme Replacement Therapy Market – By Route of Administration

1.3.4        North America Enzyme Replacement Therapy Market – By End User

1.3.5        North America Enzyme Replacement Therapy Market – By Country

2.           North America Enzyme Replacement Therapy Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Enzyme Replacement Therapy Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America – PEST Analysis

4.3         Expert Opinion

5.           North America Enzyme Replacement Therapy Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Lysosomal Storage Diseases (LSDs)

5.1.2        Rapid Regulatory Approval with Other Benefits for Drug with Orphan Drug Designation

5.2         Market Restraints

5.2.1        Cutthroat Competition among Market Players

5.3         Market Opportunities

5.3.1        Increasing Partnerships and Collaborations to Synergize the Business

5.4         Future Trends

5.4.1        Innovative Developments in ERT

5.5         Impact Analysis

6.           Enzyme Replacement Therapy Market– North America Analysis

6.1         North America Enzyme Replacement Therapy Market Revenue Forecast and Analysis

7.           North America Enzyme Replacement Therapy Market Revenue and Forecasts To 2028– by Enzyme Type

7.1         Overview

7.2         North America Enzyme Replacement Therapy Market, By Enzyme Type 2021 & 2028 (%)

7.3         Alglucosidase Alfa

7.3.1        Overview

7.3.2        Alglucosidase Alfa Revenue and Forecast to 2028 (US$ Million)

7.4         Agalsidase Beta

7.4.1        Overview

7.4.2        Agalsidase Beta - Revenue and Forecast to 2028 (US$ Million)

7.5         Imiglucerase

7.5.1        Overview

7.5.2        Imigluceras - Revenue and Forecast to 2028 (US$ Million)

7.6         Idursulfase

7.6.1        Overview

7.6.2        Idursulfase - Revenue and Forecast to 2028 (US$ Million)

7.7         Galsulfase

7.7.1        Overview

7.7.2        Galsulfase - Revenue and Forecast to 2028 (US$ Million)

7.8         Velaglucerase Alfa

7.8.1        Overview

7.8.2        Velaglucerase Alfa - Revenue and Forecast to 2028 (US$ Million)

7.9         Other Enzymes

7.9.1        Overview

7.9.2        Other Enzymes - Revenue and Forecast to 2028 (US$ Million)

8.           North America Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Therapeutic Conditions

8.1         Overview

8.2         North America Enzyme Replacement Therapy Market, By Therapeutic Conditions 2021 & 2028 (%)

8.3         Gaucher's Disease

8.3.1        Overview

8.3.2        Gaucher's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Fabry's Disease

8.4.1        Overview

8.4.2        Fabry's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Mucopolysaccharidosis (MPS)

8.5.1        Overview

8.5.2        MPS - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Pompe's Disease

8.6.1        Overview

8.6.2        Pompe's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.7         SCID

8.7.1        Overview

8.7.2        SCID - Market Revenue and Forecast to 2028 (US$ Million)

8.8         Other Therapeutic Conditions

8.8.1        Overview

8.8.2        Other Therapeutic Conditions - Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Route of Administration

9.1         Overview

9.2         North America Enzyme Replacement Therapy Market, By Route of Administration 2021 & 2028 (%)

9.3         Parenteral

9.3.1        Overview

9.3.2        Parenteral - Market Revenue and Forecast to 2028 (US$ Million)

9.4         Oral

9.4.1        Overview

9.4.2        Oral - Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Enzyme Replacement Therapy Market Analysis– By End User

10.1      Overview

10.2      North America Enzyme Replacement Therapy Market, By End User 2021 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)

10.4      Infusion Centers

10.4.1     Overview

10.4.2     Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)

10.5      Others

10.5.1     Overview

10.5.2     Others - Market Revenue and Forecasts To 2028 (US$ Million)

11.        North America Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 – Country Analysis

11.1      North America: Enzyme Replacement Therapy Market

11.1.1     Overview

11.1.3     North America: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)

11.1.3.1       US: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.1.1       Overview

11.1.3.1.2       US: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.1.3       US: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.1.4       US: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.1.5       US: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.1.6       US: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

11.1.3.2       Canada: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.2.1       Overview

11.1.3.2.2       Canada: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.2.3       Canada: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.2.4       Canada: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.2.5       Canada: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.2.6       Canada: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

11.1.3.3       Mexico: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.3.1       Overview

11.1.3.3.2       Mexico: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.3.3       Mexico: Enzyme Replacement Therapy Market, by Enzyme Type, 2019-2028 (US$ Million)

11.1.3.3.4       Mexico: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019-2028 (US$ Million)

11.1.3.3.5       Mexico: Enzyme Replacement Therapy Market, by Route of Administration, 2019-2028 (US$ Million)

11.1.3.3.6       Mexico: Enzyme Replacement Therapy Market, by End User, 2019-2028 (US$ Million)

12.        North America Enzyme Replacement Therapy Market–Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Sanofi

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      BioMarin Pharmaceutical Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Takeda Pharmaceutical Company Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      AbbVie Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Alexion Pharmaceuticals, Inc. (AstraZeneca)

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     WOT Analysis

13.6.6     Key Developments

13.7      Amicus Therapeutics

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Recordati S.p.A.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      CHIESI Farmaceutici S.p.A.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Pfizer Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             US: Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 3.             US Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4.             US Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             Canada Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 8.             Canada Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 11.          Mexico Enzyme Replacement Therapy Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Recent Inorganic Growth Strategies in the Enzyme Replacement Therapy Market

Table 14.          Recent Organic Growth Strategies in the Enzyme Replacement Therapy Market

Table 15.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Enzyme Replacement Therapy Market Segmentation

Figure 2.           North America Enzyme Replacement Therapy Market Segmentation, By Country

Figure 3.           North America Enzyme Replacement Therapy Market Overview

Figure 4.           North America Enzyme Replacement Therapy Market, By Enzyme Type

Figure 5.           North America Enzyme Replacement Therapy Market, By Country

Figure 6.           North America: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           North America Impact Analysis

Figure 9.           North America Enzyme Replacement Therapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America Enzyme Replacement Therapy Market, by Enzyme Type 2021 & 2028 (%)

Figure 11.        North America Alglucosidase Alfa Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        North America Agalsidase Beta - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        North America Imiglucerase - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        North America Idursulfase - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        North America Galsulfase - Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        North America Velaglucerase Alfa - Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        North America Other Enzymes - Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        North America Enzyme Replacement Therapy Market, by Therapeutic Conditions 2021 & 2028 (%)

Figure 19.        North America Gaucher's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        North America Fabry's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        North America MPS - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        North America Pompe's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        North America SCID - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        North America Other Therapeutic Conditions - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        North America Enzyme Replacement Therapy Market, by Route of Administration 2021 & 2028 (%)

Figure 26.        North America Parenteral - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        North America Oral - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        North America Enzyme Replacement Therapy Market, by End User 2021 & 2028 (%)

Figure 29.        North America Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        North America Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        North America Others- Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32.        North America: Enzyme Replacement Therapy Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33.        North America: Enzyme Replacement Therapy Market, by Country, 2021 & 2028 (%)

Figure 34.        US: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Canada: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Mexico: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)